The global oral dose packaging market is anticipated to accumulate a market value of US$ 105.66 billion in 2023 and is expected to garner a valuation of US$ 504 billion by exhibiting a CAGR of 16.91% in the forecast period 2023 to 2033. The market for oral dose packaging market reflected a growth rate of 11% CAGR in the historical period 2018 to 2022.
The flourishing growth in pharmaceutical sector is one of the primary growth driving factors for the oral dose packaging market. The pharmaceutical industry has been expanding swiftly in recent years due to scientific and technological advancements, and this trend is anticipated to continue during the projection period, particularly in developing nations like China, India, and Brazil.
Key players in the pharmaceutical packaging industry are showing keen interest in the oral medicine packaging market as it has a huge advantage over the other pharmaceutical packaging options. The potential of oral drug packaging to cater to the specific needs of the handicapped and elderly population by integrating their needs into packaging designs is propelling growth in the market. This makes the product a lot more convenient for them to use.
In the developed economies the ageing population is witnessing an upsurge and as a result of its ease and convenience, the oral drug packaging market is on the rise. On the other hand, the oral drug packaging of liquids is considered to be of critical importance by pharmaceutical companies. The oral liquid packaging not only improves the visibility of the product but also helps in enhancing the brand perception among the people, hence aiding in expansion of the target market.
Increasing number of people preferring alternatives like Ayurveda and homeopathy to evade side effects associated with certain allopathic treatments is expected to boost the market growth.
The oral drug packaging market is greatly benefitted from this as oral drug packaging is the most widely used and ideal packaging solution in both the streams as a majority of treatments involved use of oral form of drug delivery.
Apart from this, rising demand for packaging to enhance the protection of pharmaceutical dosage form led to the strong growth of oral liquid packaging market. The packaging material is an essential part of pharmaceutical products which intends to protect the product from external environment.
Oral liquid packaging enhances aesthetic value of the product and have vast applications in pharmaceuticals sectors which is driving growth of the oral liquid packaging market.
On the regional end, North America is expected to dominated the market with a revenue share of over 38% by end of the forecast period. The presence of several manufacturers of pharmaceutical plastic bottles in the country, like Gerresheimer AG, AptarGroup Inc., Amcor Ltd., and Berry Plastics Group, Inc., are expected to create a positive impact on the demand for pharmaceutical plastic bottles which will boost the market of oral dose packaging materials.
Likewise, Asia Pacific is expected to register the fastest CAGR of 15.2% during the forecast period. Increasing health awareness among consumers in this region, especially in developing countries including India and China, coupled with the inflating disposable income levels is expected to foster growth in the pharmaceutical industry during the forecast period accelerating demand for its packaging.
China is expected to dominated the Asia Pacific regional market owing to rising government initiatives, like ‘Healthy China 2020’, expanding contract-manufacturing activities, and burgeoning aging population.
Data Points
Key Statistics
Expected Market Value in 2023
US$ 105.66 billion
Projected Market Value in 2033
US$ 504 billion
Growth Rate (2023 to 2033)
16.91% CAGR
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How Competitive is the Market?
Recent developments and breakthroughs in technology, mergers, acquisitions, tie-ups, and partnerships within the companies involved in manufacturing oral dose packaging are expected to create lucrative opportunities for market growth during the forecast period.
In August 2021, Klöckner Pentaplast Group (United Kingdom), a manufacturer of high barrier protective packaging materials, introduced ‘kpNext’, its first-to-market innovation in recyclable polyethylene terephthalate (PET) blister films.
In July 2021, Keystone Folding Box Co. (USA) announced of increased demand for its paperboard-based blister packs for pharmaceutical packaging. This rise in demand was triggered by the introduction of new environmental sustainability legislation in India and increased demand for child-resistant pharmaceuticals packaging in the United States.
In April 2021, Amcor Plc launched customer trials for a its latest mono-material, recyclable polyethylene blister pack-AmSky. This brand puts an end to the use of polyvinyl chloride, making recycling possible.
Oral dose packaging is a primary type of packaging used for packaging of pharmaceutical products. Oral dose packaging offers broad range of oral dose forms, batch sizes and packaging for pharmaceutical products formats such as Blister packaging for capsules, tablets, and soft gels, bottling of oral liquids, bottling of oral solids, stick packs and many more.
It also includes containers such as blisters, prefilled syringes cartridges, ampoules, and vials.
Moreover, adoption of other delivery products instead of oral dose packaging like droppers, syringes and cylindrical spoons with oral dosing is expected to restrict the market growth.
What is Driving Demand for Oral Dose Packaging Market?
Growing healthcare and pharmaceutical industry is expected to propel the growth of oral dose packaging market. Demand for oral dose packaging for pharmaceuticals products has increased in recent years in economies such as India, Africa, Brazil, Russia, and China owing to rising concerns of quality in the pharmaceutical sector.
The factors such as increasing awareness about the advantages of good healthcare systems, enhanced lifestyle of people, rising concern about hygiene, higher life expectancy, and increasing population of the world augments the demand for oral dose packaging market.
Find your sweet spots for generating winning opportunities in this market.
Growing Demand for Primary Pharmaceutical Packaging is Driving the Adoption of Oral Dose Packaging Market
The products which came in direct contact with the medicine or drug are primary pharmaceutical packaging. These products are mainly made up of glass bottles, containers, plastic bottles, bottles, pre-filled syringes, cartridges, pre-filled inhalers, medication tubes, pouches, blister packaging, and others. But for pharmaceutical packaging plastic blister packs, bottles, and ampoules & vials are commonly used.
Research and development in biotechnology, introduction and rising need of new injectable parenteral therapies, and rising demand for visibility dosage packaging for diseases like Mastopathy, coeliac disease, diabetes insipidus, and many more fuels the oral dose packaging market in coming years.
North America Oral Dose Packaging Market Outlook
North America is anticipated to constitute a highest revenue growth in the oral dose packaging market during the forecast period. Increasing awareness about healthcare and increasing cases of diseases such as diabetes, coeliac disease, and diabetes insipidus in USA propels the growth of oral dose packaging market.
Also rising investments in innovation and establishment by large pharmaceutical companies in USA propels the growth of the dose packaging market in the region.
For instance, March 2021, Pfizer announced partnership with the Medicines Manufacturing Innovation Centre (CPI). This partnership helps company to find key challenges/ opportunities and boosts efficiency within pharmaceutical sector and supply chain in pharmaceutical sector. Such developments by key vendors propels the growth of the oral dose packaging market in the region.
Also the region has presence of key suppliers of pharmaceutical products including
Presence of such top key player drives the demand oral dose packaging market in the region.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Europe Demand Outlook for Oral Dose Packaging Market
Europe is the second largest contributor in oral dose packaging market, owing to technological innovations and adoption of advanced healthcare infrastructure by large packaging manufacturing companies in the top European countries such as France, Germany, Italy, France, and United Kingdom.
Growth of healthcare industry in top economies in Europe region fuels the growth of oral dose packaging market. Germany healthcare expenditure accounted for 11.7% of the GDP and exceeds their healthcare spending to US$ 505 Bn in 2020.
The stringent government regulations about medical and healthcare industry in countries like France, Germany, Italy, United Kingdom, Spain has been one of the major driving factor for the growth of the oral dose packaging Market.
Who are the Major vendors of Oral Dose Packaging Market?
Some of the leading vendors and companies of oral dose packaging market include
Amcor plc, Inc.
Schott AG
Adelphi Healthcare Packaging
SGD SA
Stevanato Group S.p.a.
Sonoco Products Company
Klockner Pentaplast Group
West Pharmaceutical Service
Berry Global, Inc.
Comar LLC
UDG Healthcare plc
Constantia Flexibles Group GmbH, Nipro Corporation
Catalent, Inc.
Winpak Ltd.
Pacific Vial Manufacturing Inc.
WestRock Company
Gerresheimer AG
AptarGroup, Inc. among others.
These key vendors have adopted various organic/inorganic strategies, to increase customer base at global market. They spend millions of dollars into product research and development to carry off the needs of their customers for oral dose packaging market.
Furthermore, many companies are focusing on acquiring small and mid-sized organizations present in this market.
For instance, In January 202o, Catalent acquired Acorda Therapeutics, Inc. This acquisition helps company to partner the USA-based companies over dry powder inhaled dose forms.
The company able to use 90,000 sq., FDA inspected CGMP facility in Chelsea, Massachusetts, which is nearby Boston Logan International Airport and helps to thrive biotechnology networks centered on Boston and Cambridge.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
